About Us
Endovascular Engineering, Inc. (“E2”), is a mission-driven, venture-backed company focused on the development and deployment of next generation clot removal technologies that target venous thromboembolism.
Leadership Team
Key Clinical Partners
Key INVESTORS
Press Releases